Variant report
Variant | nsv948156 |
---|---|
Chromosome Location | chr10:99067716-99072148 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:40)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:40 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr10:99068141-99068401 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr10:99071218-99071231 | Hela-S3 | cervix: | n/a | n/a |
3 | CEBPB | chr10:99068265-99068420 | HepG2 | liver: | n/a | n/a |
4 | CEBPB | chr10:99068155-99068490 | A549 | lung: | n/a | n/a |
5 | CEBPB | chr10:99071199-99071358 | A549 | lung: | n/a | n/a |
6 | CEBPB | chr10:99068144-99068523 | IMR90 | lung: | n/a | n/a |
7 | CEBPB | chr10:99068119-99068533 | HepG2 | liver: | n/a | n/a |
8 | EP300 | chr10:99068225-99068379 | HepG2 | liver: | n/a | n/a |
9 | FOXA1 | chr10:99068077-99068413 | HepG2 | liver: | n/a | n/a |
10 | FOXA1 | chr10:99068048-99068406 | HepG2 | liver: | n/a | n/a |
11 | FOXA2 | chr10:99068137-99068414 | HepG2 | liver: | n/a | n/a |
12 | HEY1 | chr10:99069613-99069780 | K562 | blood: | n/a | n/a |
13 | HEY1 | chr10:99069618-99069769 | HepG2 | liver: | n/a | n/a |
14 | JUND | chr10:99069261-99069569 | HepG2 | liver: | n/a | n/a |
15 | MAFK | chr10:99069357-99069402 | HepG2 | liver: | n/a | n/a |
16 | MAFK | chr10:99069377-99069429 | HepG2 | liver: | n/a | n/a |
17 | MAX | chr10:99071141-99071309 | NB4 | blood: | n/a | n/a |
18 | POLR2A | chr10:99069595-99069738 | GM12878 | blood: | n/a | n/a |
19 | POLR2A | chr10:99069585-99069826 | GM12878 | blood: | n/a | n/a |
20 | POLR2A | chr10:99069018-99069140 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | POLR2A | chr10:99071715-99071817 | K562 | blood: | n/a | n/a |
22 | POLR2A | chr10:99069634-99069754 | Hela-S3 | cervix: | n/a | n/a |
23 | POLR2A | chr10:99071912-99071995 | HUVEC | blood vessel: | n/a | n/a |
24 | POLR2A | chr10:99069636-99069751 | H1-hESC | embryonic stem cell: | n/a | n/a |
25 | POLR2A | chr10:99069615-99069877 | Hela-S3 | cervix: | n/a | n/a |
26 | POLR2A | chr10:99069549-99069791 | GM12891 | blood: | n/a | n/a |
27 | POLR2A | chr10:99069630-99069760 | A549 | lung: | n/a | n/a |
28 | POLR2A | chr10:99069661-99069730 | A549 | lung: | n/a | n/a |
29 | POLR2A | chr10:99069618-99069770 | GM12878 | blood: | n/a | n/a |
30 | POLR2A | chr10:99069648-99069760 | GM12878 | blood: | n/a | n/a |
31 | POLR2A | chr10:99069666-99069722 | A549 | lung: | n/a | n/a |
32 | POLR2A | chr10:99069615-99069734 | A549 | lung: | n/a | n/a |
33 | POLR2A | chr10:99069026-99069131 | H1-hESC | embryonic stem cell: | n/a | n/a |
34 | REST | chr10:99069012-99069146 | H1-hESC | embryonic stem cell: | n/a | n/a |
35 | RFX5 | chr10:99070735-99070743 | K562 | blood: | n/a | n/a |
36 | SMC3 | chr10:99068226-99068298 | HepG2 | liver: | n/a | n/a |
37 | STAT3 | chr10:99072051-99072106 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | TAF1 | chr10:99069602-99069807 | H1-hESC | embryonic stem cell: | n/a | n/a |
39 | YY1 | chr10:99071096-99071306 | K562 | blood: | n/a | n/a |
40 | ZNF384 | chr10:99068798-99069137 | K562 | blood: | n/a | n/a |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:99066273..99068879-chr10:99069326..99071417,2 | K562 | blood: | |
2 | chr10:99070639..99072420-chr10:99078021..99080408,2 | MCF-7 | breast: | |
3 | chr10:99067120..99069373-chr10:99092057..99094640,2 | MCF-7 | breast: | |
4 | chr10:99066690..99071389-chr10:99076606..99080814,5 | MCF-7 | breast: | |
5 | chr10:99066210..99068899-chr10:99092992..99095167,2 | K562 | blood: | |
6 | chr10:99069668..99072343-chr10:99094033..99096294,2 | MCF-7 | breast: | |
7 | chr10:99067399..99070806-chr10:99092978..99095924,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000237169 | TF binding region |
ENSG00000225850 | chromatin interactions |
ENSG00000165879 | chromatin interactions |
ENSG00000237169 | chromatin interactions |
ENSG00000181274 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536145109 | chr10:99067756-99067757 | Enhancers Bivalent Enhancer | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
2 | rs548495330 | chr10:99067789-99067790 | Enhancers Bivalent Enhancer | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
3 | rs7076009 | chr10:99067809-99067810 | Enhancers | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs7075761 | chr10:99067828-99067829 | Enhancers | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs4919086 | chr10:99067833-99067834 | Enhancers | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs577426890 | chr10:99067868-99067869 | Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
7 | rs182601833 | chr10:99067893-99067894 | Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
8 | rs186727024 | chr10:99067894-99067895 | Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
9 | rs190642513 | chr10:99067916-99067917 | Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
10 | rs373441111 | chr10:99067990-99067991 | Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
11 | rs550321515 | chr10:99068047-99068048 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
12 | rs151276104 | chr10:99068111-99068112 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
13 | rs542143453 | chr10:99068128-99068129 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
14 | rs181123447 | chr10:99068169-99068170 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
15 | rs59728887 | chr10:99068364-99068365 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs59618309 | chr10:99068380-99068381 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs557453230 | chr10:99068394-99068395 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
18 | rs532073241 | chr10:99068407-99068408 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
19 | rs550690253 | chr10:99068419-99068420 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
20 | rs562326510 | chr10:99068458-99068459 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
21 | rs529718852 | chr10:99068474-99068475 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
22 | rs148609991 | chr10:99068484-99068485 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
23 | rs185565522 | chr10:99068530-99068531 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
24 | rs567316447 | chr10:99068550-99068551 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
25 | rs527444623 | chr10:99068569-99068570 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
26 | rs552405460 | chr10:99068572-99068573 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
27 | rs111894383 | chr10:99068574-99068575 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
28 | rs545168045 | chr10:99068583-99068584 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
29 | rs570708172 | chr10:99068588-99068589 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
30 | rs575657071 | chr10:99068592-99068593 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
31 | rs556654083 | chr10:99068593-99068594 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
32 | rs189585078 | chr10:99068623-99068624 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
33 | rs142138856 | chr10:99068649-99068650 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
34 | rs534133736 | chr10:99068722-99068723 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
35 | rs572408393 | chr10:99068732-99068733 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
36 | rs10786325 | chr10:99068738-99068739 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs562363451 | chr10:99068750-99068751 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
38 | rs557920748 | chr10:99068761-99068762 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
39 | rs576607921 | chr10:99068770-99068771 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
40 | rs543947731 | chr10:99068782-99068783 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
41 | rs562622497 | chr10:99068783-99068784 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
42 | rs529626077 | chr10:99068794-99068795 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
43 | rs140674552 | chr10:99068827-99068828 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
44 | rs530098761 | chr10:99068840-99068841 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
45 | rs541820976 | chr10:99068841-99068842 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
46 | rs112556146 | chr10:99068847-99068848 | Enhancers Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
47 | rs560443792 | chr10:99068896-99068897 | Enhancers Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
48 | rs368336844 | chr10:99068897-99068898 | Enhancers Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
49 | rs73326879 | chr10:99068956-99068957 | Enhancers Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs58075430 | chr10:99068998-99068999 | Enhancers Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Paraganglioma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21364760 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Autosomal dominant partial epilepsy | 18472482 | CNVD |
Breast cancer | 16397240 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Ependymoma | 20639864 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:99066600-99068200 | Enhancers | Liver | Liver |
2 | chr10:99067000-99068000 | Enhancers | K562 | blood |
3 | chr10:99067200-99067800 | Bivalent Enhancer | HepG2 | liver |
4 | chr10:99067200-99068000 | Enhancers | Psoas Muscle | Psoas |
5 | chr10:99067200-99068200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr10:99067200-99068400 | Enhancers | Skeletal Muscle Male | skeletal muscle |
7 | chr10:99067200-99068600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
8 | chr10:99067200-99068800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
9 | chr10:99067200-99069000 | Enhancers | Primary monocytes fromperipheralblood | blood |
10 | chr10:99067600-99068000 | Enhancers | Aorta | Aorta |
11 | chr10:99067800-99069800 | Enhancers | HepG2 | liver |
12 | chr10:99068000-99072000 | Weak transcription | K562 | blood |
13 | chr10:99068200-99069400 | Weak transcription | Liver | Liver |
14 | chr10:99068800-99072800 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
15 | chr10:99069000-99073200 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
16 | chr10:99069000-99073600 | Weak transcription | Primary monocytes fromperipheralblood | blood |
17 | chr10:99069400-99069800 | Enhancers | Liver | Liver |
18 | chr10:99069800-99075400 | Weak transcription | HepG2 | liver |
19 | chr10:99071000-99071600 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
20 | chr10:99072000-99073000 | Enhancers | K562 | blood |